Developing Drugs for Tissue-Agnostic Indications: A Paradigm Shift in Leveraging Cancer Biology for Precision Medicine.

导出 OA

翻译打印收藏纠错

第一作者： Nathan D,Seligson

第一单位： Department of Pharmacotherapy and Translational Research, University of Florida, Jacksonville, Florida, USA.;Center for Pharmacogenomics and Translational Research, Nemours Children's Specialty Care, Jacksonville, Florida, USA.

作者： Nathan D,Seligson ^[1] ; Todd C,Knepper ^[2] ; Susanne,Ragg ^[3] ; Christine M,Walko ^[2]

作者单位： Department of Pharmacotherapy and Translational Research, University of Florida, Jacksonville, Florida, USA.;Center for Pharmacogenomics and Translational Research, Nemours Children's Specialty Care, Jacksonville, Florida, USA. ^[1] Department of Individualized Cancer Management, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. ^[2] Department of Pediatrics, College of Medicine-Jacksonville, University of Florida, Jacksonville, Florida, USA. ^[3]

主题词抗肿瘤药(Antineoplastic Agents);人类(Humans);肿瘤(Neoplasms);美国(United States);美国食品和药物管理局(United States Food and Drug Administration)

DOI 10.1002/cpt.1946

PMID 32535906

发布时间 2021-05-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交